Virus capsids assemble through the repeated interaction of well-define
d protein subunits in a highly specific process. Basic research into t
he mechanism of protein polymerisation and virus assembly suggest that
inhibition of the protein-protein interactions necessary for assembly
is a valid therapeutic strategy. Computer models of virus-capsid asse
mbly have located vulnerable stages in assembly, and small-molecule in
hibitors of virus assembly have been identified. The challenge will be
identifying agents that block assembly with the required specificity.